Reduced Levels of miR-145-3p Drive Cell Cycle Progression in Advanced High-Grade Serous Ovarian Cancer
Author Information
Author(s): González-Cantó Eva, Monteiro Mariana, Aghababyan Cristina, Ferrero-Micó Ana, Navarro-Serna Sergio, Mellado-López Maravillas, Tomás-Pérez Sarai, Sandoval Juan, Llueca Antoni, Herreros-Pomares Alejandro, Gilabert-Estellés Juan, Pérez-García Vicente, Marí-Alexandre Josep
Primary Institution: Research Laboratory in Biomarkers in Reproduction, Obstetrics and Gynecology, Research Foundation of the General University Hospital of Valencia, Spain
Hypothesis
The study investigates the role of miR-145-3p in cell cycle regulation and its potential as a therapeutic target in high-grade serous ovarian cancer.
Conclusion
The downregulation of miR-145-3p enhances cell proliferation and motility in high-grade serous ovarian cancer, suggesting its restoration could be a therapeutic target.
Supporting Evidence
- 20 differentially expressed miRNAs were identified in high-grade serous ovarian cancer tissues.
- miR-145-3p was consistently downregulated post-neoadjuvant therapy.
- Overexpression of miR-145-3p significantly reduced cell migration.
- miR-145-3p overexpression induced G0/G1 cell cycle arrest.
Takeaway
This study found that a tiny molecule called miR-145-3p helps control how fast cancer cells grow, and fixing its levels might help treat ovarian cancer better.
Methodology
The study involved high-throughput miRNA sequencing, RT-qPCR validation, and functional assays to analyze miRNA expression and its effects on cell migration and cell cycle.
Limitations
The study acknowledges that miR-145-3p levels were not restored after demethylating treatment, indicating potential additional regulatory mechanisms.
Participant Demographics
Patients were surgically treated for high-grade serous ovarian cancer at two hospitals in Spain, with a mean age of 60.10 years.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website